Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (51.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (31.6%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- products for consumption by the general public (17%): OTC drugs, ophthalmological products (world's No. 1 producer of soft contact lenses; Acuvue brand), nutritional products, personal care products (RoC, Neutrogena brands, etc.), feminine hygiene and baby care products, etc.

At the end of 2019, Johnson & Johnson has 97 manufacturing facilities located in the United States (32), North America (11), Europe (27), Africa and Asia/Pacific (27).

Net sales break down geographically as follows: the United States (51.3%), North America (7.2%), Europe (22.5%), Asia/Pacific and Africa (19%).

Number of employees : 132 200 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Pharmaceutical40,73450%42,19851.4% +3.59%
Medical Devices26,99433.1%25,96331.6% -3.82%
Consumer13,85317%13,89816.9% +0.32%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States41,88451.4%42,09751.3% +0.51%
Europe18,75323%18,46622.5% -1.53%
Asia-Pacific, Africa14,83118.2%15,55518.9% +4.88%
Western Hemisphere Excluding United States6,1137.5%5,9417.2% -2.81%
Managers
NameAgeSinceTitle
Alex Gorsky582012Chairman & Chief Executive Officer
Joseph J. Wolk-2018Chief Financial Officer & Executive Vice President
Paulus Stoffels, Dr.592012Chief Scientific Officer
James D. Swanson-2019Global Chief Information Officer & Executive VP
Charles O. Prince692006Independent Director
Anne M. Mulcahy662012Lead Independent Director
Ronald A. Williams692011Independent Director
Ian Davis672010Independent Director
A. Eugene Washington, Dr.682012Independent Director
Mark B. McClellan, Dr.552013Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,120,289,475 2,630,645,041 84.3% 487,466,000 15.6% 84.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 220,969,423 8.39%
SSgA Funds Management, Inc. 151,549,024 5.75%
BlackRock Fund Advisors 64,803,026 2.46%
Putnam LLC 50,777,264 1.93%
Geode Capital Management LLC 38,965,156 1.48%
State Farm Investment Management Corp. 34,574,792 1.31%
Northern Trust Investments, Inc.(Investment Management) 33,586,161 1.27%
Capital Research & Management Co. 32,520,000 1.23%
Wellington Management Co. LLP 30,556,662 1.16%
Massachusetts Financial Services Co. 29,526,058 1.12%
Holdings
NameEquities%Valuation
Idorsia Ltd (IDIA) 11,793,2208.28%377,114,155 USD
Adimmune Corporation (4142) 18,715,0004.58%47,002,348 USD
Cryo-Cell International, Inc. (CCEL) 151,2242.00%1,253,647 USD
Markets and indexes
- NYSE
- Main Market
- DJIA / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  JNJ:US
- Reuters Code :  JNJ.N
- Datastream Code :  U:JNJ
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey
États-Unis (les)

Phone : +1 (732) 524 0400
Fax : +1
Internet : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
JOHNSON & JOHNSON1.01%387 947
ROCHE HOLDING AG3.31%300 745
PFIZER, INC.-2.12%213 028
MERCK & CO., INC.-9.25%208 339
NOVARTIS AG-15.79%185 171
ABBVIE INC.8.36%169 079
NOVO NORDISK A/S7.23%152 364
ASTRAZENECA PLC15.25%150 058
AMGEN INC.2.61%143 302
ELI LILLY AND COMPANY16.29%138 545
BRISTOL-MYERS SQUIBB COMPANY-7.93%133 725
SANOFI0.71%133 190
GLAXOSMITHKLINE PLC-10.88%102 914
CHUGAI PHARMACEUTICAL CO., LTD.45.92%75 915
JIANGSU HENGRUI MEDICINE CO., LTD.27.79%70 547
BAYER AG-19.70%67 468
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-10.18%57 097
DAIICHI SANKYO COMPANY, LIMITED26.96%56 020
ASTELLAS PHARMA INC.-8.32%29 998
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.121.93%28 757